Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein

US7888100B2 · kind B2 · utility

Assignees

• Memorial Sloan-Kettering Cancer Research · US
• LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB
• Cornell Research Foundation, Inc. · US

Inventors

• Alexander Knuth · Frankfurt am Main, DE
• Elke Jager · Frankfurt am Main, DE
• Yao-Tseng Chen · New York, US
• Matthew Scanlan · Princeton Junction, US
• Ali Gure · New York, US
• Gerd Ritter · New York, US
• Lloyd J. Old · New York, US
• Jan Wouter Drijfhout · Leiden, NL

Key dates

• Filing date: Aug 4, 2006
• Grant date: Feb 15, 2011
• Expiry date: Jul 14, 2029

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S435/81
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to peptides which bind to MHC Class I and to MHC Class II molecules. These peptides are useful in different therapeutic and diagnostic contexts.